N-Aminomorpholine → 2-[(E)-2-(3-Butyl-5-methyl-isoxazol-4-yl)-vinyl]-4-methyl-thiazole-5-carboxylic acid morpholin-4-ylamide
Reaction equation
[CH2:1]([C:5]1[C:9](/[CH:10]=[CH:11]/[C:12]2[S:13][C:14]([C:18]([OH:20])=O)=[C:15]([CH3:17])[N:16]=2)=[C:8]([CH3:21])[O:7][N:6]=1)[CH2:2][CH2:3][CH3:4].[NH2:22][N:23]1[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1>>[N:23]1([NH:22][C:18]([C:14]2[S:13][C:12](/[CH:11]=[CH:10]/[C:9]3[C:5]([CH2:1][CH2:2][CH2:3][CH3:4])=[N:6][O:7][C:8]=3[CH3:21])=[N:16][C:15]=2[CH3:17])=[O:20])[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1Participants
3
Procedure
As described for example 102, 2-[(E)-2-(3-butyl-5-methyl-isoxazol-4-yl)-vinyl]-4-methyl-thiazole-5-carboxylic acid (90 mg, 0.29 mmol) was converted, using 4-aminomorpholine instead of 1,1-dimethylhydrazine, to the title compound (43 mg, 37%) which was obtained as an off white solid. MS: m/e=391.3 [M+H]+.
Sources & evidence
- ORD record
- ord-048f0d24f8b844aeb3ac2986d85a27da
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08178522B2
Reaction notes
Loading…